{"id":"W2155761542","doi":"10.1345/aph.1e298","title":"Factors Associated with Celecoxib and Rofecoxib Utilization","year":2005,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"U.S. Food and Drug Administration","keywords":"Rofecoxib; Medicine; Celecoxib; Internal medicine; Intensive care medicine; Pharmacology; Cyclooxygenase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002159769,0.000142539,0.0002597262,0.00009647325,0.00004173067,0.000006507994,0.00003664489,0.00006343234,0.0003202529],"category_scores_gemma":[0.00002929522,0.0001006399,0.00005062696,0.0001432415,0.00005762598,0.0001143976,0.000004845257,0.00009459561,0.000003095594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001152117,"about_ca_system_score_gemma":0.00004339361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004883182,"about_ca_topic_score_gemma":0.00000842426,"domain_scores_codex":[0.9992301,0.0000492111,0.0001789244,0.0001444437,0.0001965994,0.0002007315],"domain_scores_gemma":[0.9994447,0.00007704928,0.0001208788,0.00009276522,0.0001307728,0.0001338033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009664115,0.000805853,0.260864,0.000179832,0.0008072635,0.00001548476,0.002418054,0.00004294917,0.6321928,0.0001747102,0.01206717,0.0894654],"study_design_scores_gemma":[0.002513002,0.0004330105,0.09181201,0.00008197538,0.00004582117,0.000001660623,0.00002947293,0.0006668538,0.8921393,0.00001209028,0.01213803,0.0001267578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973313,0.001071527,0.00004466365,0.0006883573,0.00005134553,0.0002775596,0.00000832083,0.00005163088,0.0004753392],"genre_scores_gemma":[0.9971064,0.0007476747,0.00002652559,0.001664048,0.0001301447,0.000007257392,0.00002187714,0.00002746653,0.0002686121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2599465,"threshold_uncertainty_score":0.4103976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1852359840300505,"score_gpt":0.3968872267099089,"score_spread":0.2116512426798585,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}